Precision Medicine

Pharmacogenomics: Enhancing Safety in Cancer Treatment
Research & Development Pharmacogenomics: Enhancing Safety in Cancer Treatment

In the dynamic world of modern medicine, expectations run high for treatments that are not only effective but also minimize risks. Yet, conventional cancer therapies often walk a fine line between disease eradication and severe side effects. What if there was a way to tailor treatments to each

Can Glycomine's $115M Funded Drug Transform Rare Disease Treatment?
Tech & Innovation Can Glycomine's $115M Funded Drug Transform Rare Disease Treatment?

Glycomine, a leading biotechnology company based in San Francisco, has achieved a notable milestone by raising $115 million in funding for their pioneering project, GLM101. This development is particularly significant in an economic environment where securing substantial capital remains

Can Focused Ultrasound Revolutionize Metastatic Breast Cancer Therapy?
Research & Development Can Focused Ultrasound Revolutionize Metastatic Breast Cancer Therapy?

Metastatic breast cancer remains one of the most challenging forms of cancer to treat, with only about one-third of patients surviving beyond five years post-diagnosis. Traditional treatments such as chemotherapy, radiation, and surgery have shown limited effectiveness, often accompanied by

How Does Precision Medicine Revolutionize Rare Disease Care?
Tech & Innovation How Does Precision Medicine Revolutionize Rare Disease Care?

The evolution of precision medicine is transforming the landscape of rare disease care, offering new hope through advanced diagnostic and treatment strategies. With the advent of genomic sequencing, patients and families are experiencing a shift from despair to optimism as they navigate complex

Disparities in Pancreatic Cancer Care Linked to Social Vulnerability
Tech & Innovation Disparities in Pancreatic Cancer Care Linked to Social Vulnerability

A recent study on metastatic pancreatic adenocarcinoma (mPDAC) patients reveals significant disparities in care based on race, socioeconomic status, and other social factors, impacting the outcomes and quality of care received. The study, co-authored by Dr. Diamantis Tsilimigras and Dr. Timothy M.

Study Reveals AI Bias in Healthcare Based on Socioeconomic Factors
Tech & Innovation Study Reveals AI Bias in Healthcare Based on Socioeconomic Factors

A recent study titled "Study Reveals AI Bias in Healthcare Based on Socioeconomic Factors" has brought to light significant concerns regarding the bias embedded within large language models (LLMs) used in healthcare. Conducted by researchers from the Icahn School of Medicine at Mount

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later